Dividend Logo Green Small
MENU
Advertisement.

CLYM:Climb Bio Inc - Stock Price Quote and Dividend Data

CLYM STOCK PRICE LATEST CLOSE

$1.13

EXCHANGE

NASDAQ

CLYM

Climb Bio Inc Dividend Information

Projected 12 Month Dividend Yield0.00%
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Payment TypeN/A
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone
CLYM

Climb Bio Inc Stock Price Information

CLYM Stock Price Latest Close$1.13
52-Week Low/High Stock Price$1.05 - $11.55
Percent Held by Institutions82.15%
Revenue$0
Net Income$-82,313,000
Cash Flow$-21,083,000
EPS0.04%
Market Cap$76,246,750
PE Ratio0
PE Ratio to Industry114%
Debt-Equity Ratio0.00%
Debt-Equity to Industry2.03%
Total Return Last 12 Months-57.99%
Total Return Last 3 Years-86.47%
Total Return Last 5 Years0.00%
Latest Trade DateApr. 08, 2025
CLYM

Climb Bio Inc Annual Stock Dividends

No Data available for Payment History.

CLYM

Climb Bio Inc Dividend Payment History

No dividends retrieved for CLYM
CLYM

Climb Bio Inc Other Dividend Details

Climb Bio, Inc., formerly Eliem Therapeutics, Inc., is a clinical-stage biotechnology company. Co. is focused on developing therapeutics for patients with immune-mediated diseases. Co.'s lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody designed to deplete CD19-positive B cells, including antibody-secreting cells, in order to directly reduce pathogenic autoantibodies. The reduction of autoantibodies has the potential to be disease-modifying in autoantibody-driven diseases, such as systemic lupus erythematosus, immune thrombocytopenia, and membranous nephropathy. The budoprutug is in Phase I clinical trial.

Web Sitewww.eliemtx.com
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dividend Tools

Building a successful dividend income portfolio is simple… if you have the right tools at your disposal. Here’s a sampling of Dividend Investor’s Dividend Tools, used by thousands of investors across the globe to gain a substantial edge in their portfolio strategies.

Dividend AllStar™ Ranking

Find stocks with consecutively increasing dividends:

  • = 5 years of dividend increases
  • = 10 years of dividend increases
  • = 20 years of dividend increases

Click to Learn More

Monthly Dividend Directory

Learn which investments pay out every month, including:

  • Dividend yield
  • Ex-dividend date
  • Dividend payout date… and more

Click to Learn More

Stock Screening Tools

Screen and filter thousands of dividend-paying investments with Dividend Investor’s advanced screening tools:

  • Dividend Payout Ratio
  • Consecutive Increases
  • 5-Year Total Return… and more

Click to Learn More

Climb Bio Inc Dividend Stock News and Updates

Apr. 09, 2025CLYM STOCK PRICE DECREASE: Climb Bio Inc on 04-09-2025 decreased stock price > 10% from $1.26 to $1.13

Apr. 02, 2025CLYM STOCK PRICE 52 WEEK LOW: Climb Bio Inc on 04-02-2025 hit a 52 week low of $1.20

Jan. 09, 2025CLYM STOCK PRICE DECREASE: Climb Bio Inc on 01-09-2025 decreased stock price > 10% from $2.09 to $1.87

Jan. 03, 2025CLYM STOCK PRICE INCREASE: Climb Bio Inc on 01-03-2025 increased stock price > 10% from $1.80 to $2.07

Dec. 31, 2024CLYM STOCK PRICE DECREASE: Climb Bio Inc on 12-31-2024 decreased stock price > 10% from $2.10 to $1.85

Dec. 31, 2024CLYM STOCK PRICE 52 WEEK LOW: Climb Bio Inc on 12-31-2024 hit a 52 week low of $1.85

Dec. 27, 2024CLYM STOCK PRICE INCREASE: Climb Bio Inc on 12-27-2024 increased stock price > 10% from $1.98 to $2.27

Dec. 19, 2024CLYM STOCK PRICE DECREASE: Climb Bio Inc on 12-19-2024 decreased stock price > 10% from $2.34 to $2.03

More Climb Bio Inc Dividend News
Pharmaceuticals Dividend Stock News and Updates

Apr. 09, 2025MTSR STOCK PRICE DECREASE: Metsera Inc on 04-09-2025 decreased stock price > 10% from $16.45 to $14.21

Apr. 09, 2025RNTX STOCK PRICE DECREASE: Rein Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $1.64 to $1.39

Apr. 09, 2025IRD STOCK PRICE DECREASE: Opus Genetics Inc on 04-09-2025 decreased stock price > 10% from $0.85 to $0.75

Apr. 09, 2025DWTX STOCK PRICE DECREASE: Dogwood Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $4.05 to $3.61

Apr. 09, 2025KAPA STOCK PRICE DECREASE: Kairos Pharma Ltd on 04-09-2025 decreased stock price > 10% from $1.14 to $0.97

Apr. 09, 2025IBO STOCK PRICE DECREASE: Impact Biomedical Inc on 04-09-2025 decreased stock price > 10% from $0.87 to $0.65

Apr. 09, 2025ZBIO STOCK PRICE DECREASE: Zenas BioPharma Inc on 04-09-2025 decreased stock price > 10% from $7.75 to $6.77

Apr. 09, 2025EVOK STOCK PRICE DECREASE: Com Par $0.0001/Evoke Pharma Inc on 04-09-2025 decreased stock price > 10% from $2.35 to $2.07

Apr. 09, 2025TNFA STOCK PRICE DECREASE: TNF Pharmaceuticals Inc on 04-09-2025 decreased stock price > 10% from $0.37 to $0.26

Apr. 09, 2025TCRT STOCK PRICE DECREASE: Com No Par/Alaunos Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $3.00 to $2.51

More Pharmaceuticals Dividend News
X
Search Dividend Investor